Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

MUC6 (mucin 6, oligomeric mucus/gel-forming)

Written2009-12Lara Cobler, Marta Garrido, Carme de Bolós
Programa de Recerca en Cancer, IMIM-Hospital del Mar, Dr Aiguader, 88, 08003, Barcelona, Spain

(Note : for Links provided by Atlas : click)


Alias (NCBI)MUC-6
mucin 6
HGNC (Hugo) MUC6
HGNC Previous namemucin 6, gastric
LocusID (NCBI) 4588
Atlas_Id 44115
Location 11p15.5  [Link to chromosome band 11p15]
Location_base_pair Starts at 1012823 and ends at 1036718 bp from pter ( according to GRCh38/hg38-Dec_2013)  [Mapping MUC6.png]
  Location of MUC6 gene.
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)
GRINA (8q24.3)::MUC6 (11p15.5)


  Genomic organization of MUC6 gene (not to scale).
Description MUC6 gene approximately extends 24 kb-long on the chromosome 11 in the region p15.5. The central region has sequences repeated in tandem (TR) with a consensus motif composed of 507 pb. The variable number of TR (VNTR) diverges between 15 and 26, and the difference in distinct alleles is 5 kb long. Some data suggest that short MUC6 alleles are associated with Helicobacter pylori infection and gastric cancer.
Transcription MUC6 gene is composed of 33 exons and the mRNA length is approximately 8 kb. The 5' flanking region of the MUC6 gene contains a TATA box at -35/-29 and potential transcription factor binding sites are described for NFkappaB and Sp family members.
Although MUC6 promoter contains a high percentage of CpG dinucleotides (up to 75%) and a CpG island, its regulation is not influenced by epigenetics.
At present no splice variants forms have been reported.


  Schematic representation of MUC6 peptide structure (not to scale).
Description At the N-terminal region D1, D2, D' and D3 domains similar to von Willebrand factor (vWF) are present.
The TR domain composes the central region. The 169 amino acid consensus sequence has a high content of Thr-Ser-Pro containing numerous potential O-glycosilation sites.
The C-terminal region consists in two distinct regions. One with a high Thr-Ser-Pro content (STP domain), very similar to the tandem repeat region in amino acid composition, and the other region that has a high content of cystein residues. This domain has approximately 25% similarity to the CK domain of the 11p15 human mucins MUC2, MUC5AC, MUC5B and the vWF.
Expression MUC6 was initially isolated from a gastric cDNA library, and it is expressed in the deep gland cells. It is the only mucin produced by acinar cells of the duodenal Brüner's glands and it is also expressed in pancreas, endocervix and gallbladder.
Under pathological conditions, MUC6 expression can be altered, as it is reported below.
Function MUC6, together with MUC5AC, is the major component of the protective layer over the gastric surface where it acts as a selective diffusion barrier for HCl. Furthermore, the O-glycans found in the MUC6 TR have antimicrobial activity against Helicobacter pylori, inhibiting the biosynthesis of cholesteryl-alpha-D-glucopyranoside, a major cell wall component.
Homology Several orthologues of MUC6 have been identified in Mus musculus, Rattus norvegicus, Pan troglodytes and Equus caballus. The chicken and mouse Muc6 have similar domain structures with human MUC6. Furthermore, the tissue-specific expression is conserved in murine organisms.

Implicated in

Entity Gastric cancer
Disease Gastric cancer remains the second leading cause related death and the fourth most common cancer in the world, although its incidence is gradually decreasing.
Prognosis MUC6 is highly expressed in gastric mucosa and in intestinal metaplasia MUC6 levels are decreased: In incomplete metaplasia and type I complete metaplasia MUC6 is not detected, whereas it is found in type II and type III complete intestinal metaplasia. MUC6 expression is lower in intestinal-type of gastric carcinomas than in adenomas or normal mucosa suggesting that the downregulation of MUC6 may contribute to the malignant transformation of gastric epithelial cells.
MUC6 is expressed in diffuse-type gastric carcinoma and its levels are greater in early carcinomas than in advanced carcinomas, showing no relationship with the depth of the carcinoma cells invasion.
Entity Colon cancer
Disease Colorectal cancer is one of the commonest cancers and the third leading cause of cancer death. However, its incidence has decreased due to a most effective intervention and life-style changes in the western countries.
Prognosis Although in normal colon mucosa MUC6 is not expressed, it is upregulated through the adenoma-carcinoma sequence, together with the downregulation of MUC2.
Entity Salivary glands tumors
Disease Salivary gland tumors are relatively uncommon. However, mucoepidermoid carcinoma is the most frequent malignant tumor of salivary glands.
Prognosis Normal salivary glands do not express MUC6 whereas in mucoepidermoid carcinomas MUC6 is detected preferentially in mucous cells.
Entity Esophagus adenocarcinoma
Disease The frequency of adenocarcinoma of the esophagus is increasing in the western world from a result of a higher prevalence in Barrett's mucosa.
Prognosis MUC6 showed a decrease in expression with progression from Barrett's esophagus to dysplasia and to adenocarcinoma.
Entity Pancreatic cancer
Disease Pancreas cancer is a very aggressive tumor with a 5-year survival of less than 5%, and approximately 85% of them correspond to ductal adenocarcinomas.
Prognosis In normal pancreatic epithelium MUC6 is only expressed in ductal and in a minority of centroacinar cells. However, it is upregulated at early stages of pancreatic carcinogenesis and in pancreatic cancer. MUC6 expression has been related to clinicopathological factors and patient prognosis and survival in invasive ductal carcinoma.
Entity Biliary tract cancer
Disease Biliary tract carcinomas are uncommon tumors that include cholangiocarcinomas and gallbladder carcinomas. These tumors have a poor prognosis: more than 80% of the patients are unresectable with a 6-9 month survival, and this rate is increased to 5 year after surgery.
Prognosis MUC6 is expressed in normal gallbladder mucosa. However in adenomas, dysplasias and carcinomas, MUC6 tends to decrease and its expression is related to non-invasive growth. MUC6 is expressed frequently in pseudopyloric gland metaplasia as well as dysplasia and carcinoma.
Entity Lung cancer
Disease Lung cancer is the leading cause of cancer-related mortality worldwide. Despite of this its incidence is decreasing.
Prognosis MUC6 is not expressed in normal respiratory epithelium, but it has been focally detected in normal and distal epithelium from cancer patients. MUC6 levels increase significantly in the progression from atypical adenomatous hyperplasia, through bronchio alveolar carcinoma, to adenocarcinoma with mixed subtypes, suggesting that its expression might be associated with the progression of the lung adenocarcinoma. No expression of MUC6 is found in squamous lesions.
Entity Breast cancer
Disease Breast cancer is the most common cancer worldwide and the leading cause of cancer mortality in women.
Prognosis MUC6 is generally not detected in normal breast epithelium but it is overexpressed in benign breast disease (fibrocystic disease without atypia and atypical fibrocystic disease) and in breast carcinoma.
Entity Endometrial adenocarcinoma
Disease Endometrial carcinoma is the most common malignant neoplasm of the female genital tract in developed countries, and it occurs predominantly after menopause.
Prognosis MUC6 is not expressed in normal endometrial epithelium. However during endometrial neoplasia transformation, increased levels of MUC6 are detected: from simple hyperplasia, to complex hyperplasia, and in endometrial adenocarcinomas a MUC6 upregulation is found.
Entity Uterine cervix adenocarcinoma
Disease Adenocarcinoma is the second most common malignancy of the uterine cervix. Its incidence has been increasing and constitutes 10-20% of invasive cervical cancers.
Prognosis Although MUC6 is not expressed in normal cervical epithelium, in adenocarcinomas from uterine cervix; MUC6 can be detected at different levels associated to the histological type.


Mucin genes (MUC2, MUC4, MUC5AC, and MUC6) detection in normal and pathological endometrial tissues.
Alameda F, Mejias-Luque R, Garrido M, de Bolos C.
Int J Gynecol Pathol. 2007 Jan;26(1):61-5.
PMID 17197898
Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.
Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, de Bolos C, Cardesa A.
Am J Surg Pathol. 2005 Jun;29(6):806-13.
PMID 15897748
Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases.
Andrianifahanana M, Moniaux N, Batra SK.
Biochim Biophys Acta. 2006 Apr;1765(2):189-222. Epub 2006 Jan 27. (REVIEW)
PMID 16487661
Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
Awaya H, Takeshima Y, Yamasaki M, Inai K.
Am J Clin Pathol. 2004 May;121(5):644-53.
PMID 15151204
The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues.
Bartman AE, Buisine MP, Aubert JP, Niehans GA, Toribara NW, Kim YS, Kelly EJ, Crabtree JE, Ho SB.
J Pathol. 1998 Dec;186(4):398-405.
PMID 10209489
Viscous fingering of HCl through gastric mucin.
Bhaskar KR, Garik P, Turner BS, Bradley JD, Bansil R, Stanley HE, LaMont JT.
Nature. 1992 Dec 3;360(6403):458-61.
PMID 1448168
Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. I. Stomach. A relationship to gastric carcinoma.
Buisine MP, Devisme L, Maunoury V, Deschodt E, Gosselin B, Copin MC, Aubert JP, Porchet N.
J Histochem Cytochem. 2000 Dec;48(12):1657-66.
PMID 11101634
Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.
Burjonrappa SC, Reddimasu S, Nawaz Z, Gao X, Sharma P, Loggie B.
Indian J Cancer. 2007 Jan-Mar;44(1):1-5.
PMID 17401217
Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis.
Chang HJ, Kim SW, Lee BL, Hong EK, Kim WH.
Pathol Int. 2004 Aug;54(8):576-84.
PMID 15260848
Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas.
Copin MC, Buisine MP, Leteurtre E, Marquette CH, Porte H, Aubert JP, Gosselin B, Porchet N.
Hum Pathol. 2001 Mar;32(3):274-81.
PMID 11274635
MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach.
De Bolos C, Garrido M, Real FX.
Gastroenterology. 1995 Sep;109(3):723-34.
PMID 7657100
The mouse secreted gel-forming mucin gene cluster.
Escande F, Porchet N, Bernigaud A, Petitprez D, Aubert JP, Buisine MP.
Biochim Biophys Acta. 2004 Feb 20;1676(3):240-50.
PMID 14984930
MUC6 gene polymorphism in healthy individuals and in gastric cancer patients from northern Portugal.
Garcia E, Carvalho F, Amorim A, David L.
Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1071-4.
PMID 9419405
DX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
Ha Kim G, Am Song G, Youn Park D, Han Lee S, Hyun Lee D, Oh Kim T, Jae Jo H, Heo J, Hwan Kang D, Cho M.
Scand J Gastroenterol. 2006 Aug;41(8):880-6.
PMID 16803685
Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis.
Jinfeng M, Kimura W, Hirai I, Sakurai F, Moriya T, Mizutani M.
Int J Gastrointest Cancer. 2003;34(1):9-18.
PMID 15235131
Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection.
Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama J.
Science. 2004 Aug 13;305(5686):1003-6.
PMID 15310903
An inventory of mucin genes in the chicken genome shows that the mucin domain of Muc13 is encoded by multiple exons and that ovomucin is part of a locus of related gel-forming mucins.
Lang T, Hansson GC, Samuelsson T.
BMC Genomics. 2006 Aug 3;7:197.
PMID 16887038
Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns.
Lopez-Ferrer A, Curull V, Barranco C, Garrido M, Lloreta J, Real FX, de Bolos C.
Am J Respir Cell Mol Biol. 2001 Jan;24(1):22-29.
PMID 11152646
Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.
Mikami Y, Kiyokawa T, Hata S, Fujiwara K, Moriya T, Sasano H, Manabe T, Akahira J, Ito K, Tase T, Yaegashi N, Sato I, Tateno H, Naganuma H.
Mod Pathol. 2004 Aug;17(8):962-72.
PMID 15143335
Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues.
Nakajima K, Ota H, Zhang MX, Sano K, Honda T, Ishii K, Nakayama J.
J Histochem Cytochem. 2003 Dec;51(12):1689-98.
PMID 14623937
Short mucin 6 alleles are associated with H pylori infection.
Nguyen TV, Janssen M Jr, Gritters P, te Morsche RH, Drenth JP, van Asten H, Laheij RJ, Jansen JB.
World J Gastroenterol. 2006 Oct 7;12(37):6021-5.
PMID 17009402
Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS.
Oncol Rep. 2009 Sep;22(3):649-57.
PMID 19639217
Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues.
Pereira MB, Dias AJ, Reis CA, Schmitt FC.
J Clin Pathol. 2001 Mar;54(3):210-3.
PMID 11253133
Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes.
Pigny P, Guyonnet-Duperat V, Hill AS, Pratt WS, Galiegue-Zouitina S, d'Hooge MC, Laine A, Van-Seuningen I, Degand P, Gum JR, Kim YS, Swallow DM, Aubert JP, Porchet N.
Genomics. 1996 Dec 15;38(3):340-52.
PMID 8975711
Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas.
Reis CA, David L, Carvalho F, Mandel U, de Bolos C, Mirgorodskaya E, Clausen H, Sobrinho-Simoes M.
J Histochem Cytochem. 2000 Mar;48(3):377-88.
PMID 10681391
Upregulation of MUC6 mucin gene expression by NFkappaB and Sp factors.
Sakai H, Jinawath A, Yamaoka S, Yuasa Y.
Biochem Biophys Res Commun. 2005 Aug 12;333(4):1254-60.
PMID 15979574
Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder.
Sasaki M, Yamato T, Nakanuma Y, Ho SB, Kim YS.
Pathol Int. 1999 Jan;49(1):38-44.
PMID 10227723
The carboxyl-terminal sequence of the human secretory mucin, MUC6. Analysis Of the primary amino acid sequence.
Toribara NW, Ho SB, Gum E, Gum JR Jr, Lau P, Kim YS.
J Biol Chem. 1997 Jun 27;272(26):16398-403.
PMID 9195947
Variable number tandem repeat polymorphism of the mucin genes located in the complex on 11p15.5.
Vinall LE, Hill AS, Pigny P, Pratt WS, Toribara N, Gum JR, Kim YS, Porchet N, Aubert JP, Swallow DM.
Hum Genet. 1998 Mar;102(3):357-66.
PMID 9544852
Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.
Vincent A, Perrais M, Desseyn JL, Aubert JP, Pigny P, Van Seuningen I.
Oncogene. 2007 Oct 4;26(45):6566-76. Epub 2007 Apr 30.
PMID 17471237
Regulation of mucin genes in chronic inflammatory airway diseases.
Voynow JA, Gendler SJ, Rose MC.
Am J Respir Cell Mol Biol. 2006 Jun;34(6):661-5. Epub 2006 Feb 2. (REVIEW)
PMID 16456183
MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.
Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Takano Y.
Cancer Res Clin Oncol. 2006 Dec;132(12):817-23. Epub 2006 Jun 29.
PMID 16807756
Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors.
de Bolos C, Real FX, Lopez-Ferrer A.
Front Biosci. 2001 Oct 1;6:D1256-63. (REVIEW)
PMID 11578953


This paper should be referenced as such :
Cobler, L ; Garrido, M ; de, Bolòs C
MUC6 (mucin 6, oligomeric mucus/gel-forming)
Atlas Genet Cytogenet Oncol Haematol. 2010;14(10):918-922.
Free journal version : [ pdf ]   [ DOI ]

External links


HGNC (Hugo)MUC6   7517
Atlas Explorer : (Salamanque)MUC6
Entrez_Gene (NCBI)MUC6    mucin 6, oligomeric mucus/gel-forming
GeneCards (Weizmann)MUC6
Ensembl hg19 (Hinxton)ENSG00000184956 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000184956 [Gene_View]  ENSG00000184956 [Sequence]  chr11:1012823-1036718 [Contig_View]  MUC6 [Vega]
ICGC DataPortalENSG00000184956
TCGA cBioPortalMUC6
AceView (NCBI)MUC6
Genatlas (Paris)MUC6
SOURCE (Princeton)MUC6
Genetics Home Reference (NIH)MUC6
Genomic and cartography
GoldenPath hg38 (UCSC)MUC6  -     chr11:1012823-1036718 -  11p15.5   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)MUC6  -     11p15.5   [Description]    (hg19-Feb_2009)
GoldenPathMUC6 - 11p15.5 [CytoView hg19]  MUC6 - 11p15.5 [CytoView hg38]
Genome Data Viewer NCBIMUC6 [Mapview hg19]  
Gene and transcription
Genbank (Entrez)AK092533 AK096772 AK098503 AY312160 AY458429
RefSeq transcript (Entrez)NM_005961
Consensus coding sequences : CCDS (NCBI)MUC6
Gene ExpressionMUC6 [ NCBI-GEO ]   MUC6 [ EBI - ARRAY_EXPRESS ]   MUC6 [ SEEK ]   MUC6 [ MEM ]
Gene Expression Viewer (FireBrowse)MUC6 [ Firebrowse - Broad ]
GenevisibleExpression of MUC6 in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)4588
GTEX Portal (Tissue expression)MUC6
Human Protein AtlasENSG00000184956-MUC6 [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ6W4X9   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtQ6W4X9  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProQ6W4X9
Domaine pattern : Prosite (Expaxy)CTCK_2 (PS01225)    VWFD (PS51233)   
Domains : Interpro (EBI)Cys_knot_C    MUC6    Ser_inhib-like_sf    TIL_dom    Unchr_dom_Cys-rich    VWF_dom    VWF_type-D   
Domain families : Pfam (Sanger)C8 (PF08742)    TIL (PF01826)    VWD (PF00094)   
Domain families : Pfam (NCBI)pfam08742    pfam01826    pfam00094   
Domain families : Smart (EMBL)C8 (SM00832)  CT (SM00041)  VWC_out (SM00215)  VWD (SM00216)  
Conserved Domain (NCBI)MUC6
AlphaFold pdb e-kbQ6W4X9   
Human Protein Atlas [tissue]ENSG00000184956-MUC6 [tissue]
Protein Interaction databases
IntAct (EBI)Q6W4X9
Ontologies - Pathways
Ontology : AmiGOextracellular matrix structural constituent  extracellular space  Golgi lumen  plasma membrane  maintenance of gastrointestinal epithelium  extracellular matrix  
Ontology : EGO-EBIextracellular matrix structural constituent  extracellular space  Golgi lumen  plasma membrane  maintenance of gastrointestinal epithelium  extracellular matrix  
REACTOMEQ6W4X9 [protein]
REACTOME PathwaysR-HSA-977068 [pathway]   
NDEx NetworkMUC6
Atlas of Cancer Signalling NetworkMUC6
Wikipedia pathwaysMUC6
Orthology - Evolution
GeneTree (enSembl)ENSG00000184956
Phylogenetic Trees/Animal Genes : TreeFamMUC6
Homologs : HomoloGeneMUC6
Homology/Alignments : Family Browser (UCSC)MUC6
Gene fusions - Rearrangements
Fusion : MitelmanGRINA::MUC6 [8q24.3/11p15.5]  
Fusion : FusionHubAC096579.13--MUC6    CTSE--MUC6    DPCR1--MUC6    EGR1--MUC6    ERBB2--MUC6    GRINA--MUC6    IGH@--MUC6    IGHA1--MUC6    IGHA2--MUC6    IGK@--MUC6   
IGKC--MUC6    IGLC2--MUC6    IGLC3--MUC6    KRT13--MUC6    MUC5AC--MUC6    MUC6--IGHA1    MUC6--MS5    MUC6--MTATP8P1    MUC6--PCBD2    MUC6--PGA3   
MUC6--PGC    PARP3--MUC6    PGA3--MUC6    PGA4--MUC6    PGA5--MUC6    PGC--MUC6    PTCH1--MUC6   
Fusion : QuiverMUC6
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerMUC6 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)MUC6
Exome Variant ServerMUC6
GNOMAD BrowserENSG00000184956
Varsome BrowserMUC6
ACMGMUC6 variants
Genomic Variants (DGV)MUC6 [DGVbeta]
DECIPHERMUC6 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisMUC6 
ICGC Data PortalMUC6 
TCGA Data PortalMUC6 
Broad Tumor PortalMUC6
OASIS PortalMUC6 [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICMUC6  [overview]  [genome browser]  [tissue]  [distribution]  
Somatic Mutations in Cancer : COSMIC3DMUC6
Mutations and Diseases : HGMDMUC6
LOVD (Leiden Open Variation Database)[gene] [transcripts] [variants]
DgiDB (Drug Gene Interaction Database)MUC6
DoCM (Curated mutations)MUC6
CIViC (Clinical Interpretations of Variants in Cancer)MUC6
NCG (London)MUC6
Impact of mutations[PolyPhen2] [Provean] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Genetic Testing Registry MUC6
NextProtQ6W4X9 [Medical]
Target ValidationMUC6
Huge Navigator MUC6 [HugePedia]
Clinical trials, drugs, therapy
Protein Interactions : CTDMUC6
Pharm GKB GenePA31322
Clinical trialMUC6
DataMed IndexMUC6
PubMed67 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Thu Jan 20 14:12:33 CET 2022

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us